District Court Awards Post-Markman Attorneys’ Fees After Plaintiff Continued to Litigate Claims That Became Baseless in Light of the Court’s Markman Order

Mar 4, 2020

Reading Time : 2 min

Plaintiff asserted 11 patents relating generally to methods of multimedia communications. The court found that eight of those patents claimed unpatentable subject matter and were invalid under 35 U.S.C. § 101. After claim construction the court granted defendant’s motions for summary judgment, finding that the defendant did not infringe one patent and that another was invalid under § 101. Plaintiff stipulated to noninfringement of the final remaining patent but reserved its right to appeal the claim construction issue. It later appealed.

The Federal Circuit affirmed the court’s summary judgment finding and all claim construction determinations but one. But because plaintiff had failed to articulate an infringement position under the affirmed claim constructions, the Federal Circuit had no choice but to remand the case. The parties eventually stipulated to dismissal and defendant moved for attorneys’ fees.

The court noted that an infringement case that is substantively weak when filed can become exceptional if claim construction renders the claims-at-issue baseless. Here, plaintiff’s case was initially weak—its claims relating to eight of the patents were dismissed because the patents were invalid under 35 U.S.C. § 101. But the case was not so extraordinarily weak as to be exceptional at inception. After the Markman order, however, plaintiff should have known that each remaining claim was baseless. Specifically, the court’s later invalidation of the claims of one patent was the “clear and necessary consequence of the claim construction.” And for the claims of the patent for which the court ultimately granted summary judgment of no infringement, plaintiff’s continued infringement theory directly contradicted the court’s Markman order. Instead of dismissing its claims based on these patents,  plaintiff “avoided summary judgment by stipulating to noninfringement, proceeded to appeal without a viable theory of infringement, and then prolonged the case by insisting on remand—caused by [its] own lack of clarity and specificity in the stipulation—without an infringement theory.” Continuing to litigate was, thus, objectively unreasonable and the case was exceptional. The court therefore awarded attorneys’ fees pursuant to 35 U.S.C. § 285.

Practice Tip: In order for a party to recover attorneys’ fees, a case need not be exceptional at inception. A party should re-evaluate whether any asserted claims or defenses become baseless after potentially case dispositive events like claim construction.

Innovation Sciences, LLC v. Amazon.com, Inc., No. 1:16-cv-00861 (E.D. Va. Feb. 18, 2020) (Grady, J.)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.